尿酸結晶 | Uric Acid Crystal (Flexi)

MRP Crystal Flexi
HK$0.00
In stock
1
Product Details
品牌 Brand: 科學+家 SCIENTIST HOME | 拜塞 BIOSCI

尿酸結晶

在過去的幾十年裏,發達國家的高尿酸血症和痛風的患病率都在上升,因此痛風的負擔也在新增。高尿酸血症和痛風與心血管问题的關係以及高尿酸血症干預進一步獲益的機會最近在文獻中被強調。

成像技術已被證明可用於檢測尿酸鹽沉積,甚至在出現第一個臨床症狀之前,就能夠評估沉積程度並在降尿酸治療期間提供晶體消耗的客觀測量。

因此,針對疾病負擔的不同階段和治療的不同階段,建議了不同的靶點。

最終的戰略目標是完全溶解組織中的尿酸鹽晶體,從而避免肌肉骨骼結構的進一步症狀和結構損傷。

總之,有證據表明,早期治療痛風和相關的共病是可取的,新的成像科技可能有助於評估特定患者的沉積負擔和對降低尿酸治療的反應。最後,痛風患者醫療保健的最終戰略目標是完全分解尿酸鹽晶體沉積。

可能適合多學科復康調理:

  • 減輕尿酸鈉炎症 (1)
  • 高尿酸炎症的改善 (2)
  • 尿酸肾结石 (3)
  • 痛風性關節炎 (4)
  • 高尿酸心血管 (5)
  • 尿酸結締鈣化 (6)
  • 尿酸鈉冠狀動脈鈣化 (7)
  • 焦磷酸鈣結晶溶解 (8)
  • 溶解草酸鈣結晶 (9)

尿酸結晶 - 多學科研證復康方案

  • 藥物及其他醫療方案, 請遵醫從醫生建議
  • 飲食營養請依營養師指引
  • 運動及或心理輔導, 請參考各專家建議
  • 為免錯誤診斷及漏診, 請上傳最近一個月醫院的專業診斷報告

可能適合的補充劑支援:

標準組合:

A) 試用時期: 2星期

  1. 嘌呤研究 x 1
  2. 結晶研究 (84 粒) x 1瓶
  3. 結晶研究霜劑 x 1
  4. 鈣化研究霜劑 x 1
  5. 水解混合明膠 x 2

復康疗程: 6至9个月或以上

如你有任何疾病, 請遵照閣下醫生的完整醫療方案; 而是否使用多學科復康方案前, 你必須咨詢主診醫生的意見, 如果閣下的主診醫生不建議您加入補充劑調理組合, 請你不要使用。如果你需要尋求其他醫生作第二咨詢, 閣下可聯絡我們線上<無邊界醫生>或你自己城市內的其他專業醫生的再診斷。


__


Uric Acid Crystal

The prevalence of both hyperuricemia and gout has risen in the last decades in developed countries and therefore the burden of gout has increased. The association of hyperuricemia and gout with cardiovascular outcomes and the opportunity of further benefits of intervention on hyperuricemia have been recently highlighted in the literature.

Imaging techniques have proven to be useful for detection of urate deposition, even prior to the first clinical symptoms, enabling the evaluation of the extent of deposition and providing objective measurement of crystal depletion during urate-lowering treatment.

Treating to target is increasingly used as the approach to treatment of diverse diseases. Therefore, different targets have been recommended for different stages of the burden of disease and for different stages of treatment.

The final strategic target, to which any effort should be taken into consideration, is to completely dissolve urate crystals in tissues and therefore avoid further symptoms and structural damage of involved musculoskeletal structures.

In summary, evidence suggest that an early approach to the treatment of gout and associated comorbidities is advisable, that new imaging techniques may help to evaluate both the burden of deposition and response to urate-lowering treatment in selected patients, and finally that the final strategic objective of healthcare for patients with gout is to completely resolve urate crystal deposits.

Suggested multidisciplinary rehabilitation:

  • Reduce sodium urate inflammation (1)
  • Improvement in hyperuricemia and inflammation (2)
  • Uric acid kidney stones (3)
  • Gouty arthritis (4)
  • High uric acid cardiovascular (5)
  • Uric acid connective calcification (6)
  • Sodium urate coronary artery calcification (7)
  • Calcium pyrophosphate crystal dissolution (8)
  • Dissolve calcium oxalate crystal (9)

Multidisciplinary rehabilitation program for Uric Acid Crystal

  • Please follow doctor's advice on drugs and other medical plans.
  • Please follow nutritionist's guidance.
  • For sports or psychological counseling, please refer to the experts' suggestions.
  • In order to avoid misdiagnosis, please upload the latest health report from hospital (preferably dated within a month).

Suggested supplements:

Standard combination:

A) Trial period: 2 weeks

  1. PS Mulberry Kohki x 1 bottle
  2. Crystallized Study (84 caps) x 1 bottle
  3. Crystallized Study Cream x 1 unit
  4. Calcification Cream x 1 unit
  5. Mixed Gelatine Hydrolysate x 2 bottles

Rehabilitation period: 6 to 9 months or above

If you have a medical condition, please follow your doctor's medical treatment plan. Do consult your medical doctor before using the Multidisciplinary Rehabilitation Program (MRP). Please do not proceed if your medical doctor does not recommend the use of our MRP. If you'd like to seek a second opinion from other doctors, you may contact our online "Doctors Without Border", or other professional doctors at your convenience.

__


Ref:

Fernando Perez-Ruiz 1 , Nicola Dalbeth, Tomas Bardin A review of uric acid, crystal deposition disease, and gout. Review Adv Ther . 2015 Jan;32(1):31-41. doi: 10.1007/s12325-014-0175-z. Epub 2014 Dec 23. PMID: 25533440 PMCID: PMC4311063 DOI: 10.1007/s12325-014-0175-z

__


本品等並非根據《藥劑業及毒藥條例》或《中醫藥條例》注册。任何對其提出的宣稱均不受此類登記評估的約束。本產品不用於診斷、治療或預防任何疾病。

This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease.

Save this product for later